Microbiota and Lung Cancer. Opportunities and Challenges for Improving Immunotherapy Efficacy

by Maitane Ocáriz-Díez, Maitane Ocáriz-Díez, Mara Cruellas, Mara Cruellas, Marta Gascón, Marta Gascón, Rodrigo Lastra, Rodrigo Lastra, Luis Martínez-Lostao, Luis Martínez-Lostao, Luis Martínez-Lostao, Luis Martínez-Lostao, Luis Martínez-Lostao, Ariel Ramírez-Labrada, José Ramón Paño, José Ramón Paño, Andrea Sesma, Andrea Sesma, Irene Torres, Irene Torres, Alfonso Yubero, Alfonso Yubero, Julián Pardo, Julián Pardo, Julián Pardo, Julián Pardo, Dolores Isla, Dolores Isla, Eva M. Gálvez
Published 2020-09-01

Importance of TRAIL Molecular Anatomy in Receptor Oligomerization and Signaling. Implications for Cancer Therapy

by Javier Naval, Diego de Miguel, Ana Gallego-Lleyda, Alberto Anel, Luis Martinez-Lostao
Published 2019-03-01

Role of Exosomes in the Regulation of T-Cell Mediated Immune Responses and in Autoimmune Disease

by Alberto Anel, Ana Gallego-Lleyda, Diego de Miguel, Javier Naval, Luis Martínez-Lostao
Published 2019-02-01

The Multifaceted Function of Granzymes in Sepsis: Some Facts and a Lot to Discover

by Marcela Garzón-Tituaña, Maykel A. Arias, José L. Sierra-Monzón, José L. Sierra-Monzón, Elena Morte-Romea, Elena Morte-Romea, Llipsy Santiago, Ariel Ramirez-Labrada, Luis Martinez-Lostao, Luis Martinez-Lostao, Luis Martinez-Lostao, José R. Paño-Pardo, José R. Paño-Pardo, Eva M. Galvez, Julián Pardo, Julián Pardo, Julián Pardo, Julián Pardo, Julián Pardo
Published 2020-06-01

Intracellular Delivery of Biologically-Active Fungal Metabolite Gliotoxin Using Magnetic Nanoparticles

by Laura Comas, Esther Polo, M Pilar Domingo, Yulán Hernández, Maykel Arias, Patricia Esteban, Luis Martínez-Lostao, Julián Pardo, Jesús Martínez de la Fuente, Eva M Gálvez
Published 2019-04-01

Early Measurement of Blood sST2 Is a Good Predictor of Death and Poor Outcomes in Patients Admitted for COVID-19 Infection

by Marta Sánchez-Marteles, Jorge Rubio-Gracia, Natacha Peña-Fresneda, Vanesa Garcés-Horna, Borja Gracia-Tello, Luis Martínez-Lostao, Silvia Crespo-Aznárez, Juan Ignacio Pérez-Calvo, Ignacio Giménez-López
Published 2021-08-01

Intratumoral Versus Circulating Lymphoid Cells as Predictive Biomarkers in Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: Is the Easiest Path the Best One?

by Marta Gascón, Dolores Isla, Mara Cruellas, Eva M. Gálvez, Rodrigo Lastra, Maitane Ocáriz, José Ramón Paño, Ariel Ramírez, Andrea Sesma, Irene Torres-Ramón, Alfonso Yubero, Julián Pardo, Luis Martínez-Lostao
Published 2020-06-01

Anti-tumoral potential of a human granulysin-based, CEA-targeted cytolytic immunotoxin

by Raquel Ibáñez-Pérez, Patricia Guerrero-Ochoa, Sameer Al-Wasaby, Rocío Navarro, Antonio Tapia-Galisteo, Diego De Miguel, Oscar Gonzalo, Blanca Conde, Luis Martínez-Lostao, Ramón Hurtado-Guerrero, Laura Sanz, Alberto Anel
Published 2019-11-01

Mutations in the <i>ND2</i> Subunit of Mitochondrial Complex I Are Sufficient to Confer Increased Tumorigenic and Metastatic Potential to Cancer Cells

by Joaquín Marco-Brualla, Sameer Al-Wasaby, Ruth Soler, Eduardo Romanos, Blanca Conde, Raquel Justo-Méndez, José A. Enríquez, Patricio Fernández-Silva, Luis Martínez-Lostao, Martín Villalba, Raquel Moreno-Loshuertos, Alberto Anel
Published 2019-07-01

From Tumor Mutational Burden to Blood T Cell Receptor: Looking for the Best Predictive Biomarker in Lung Cancer Treated with Immunotherapy

by Andrea Sesma, Julián Pardo, Mara Cruellas, Eva M. Gálvez, Marta Gascón, Dolores Isla, Luis Martínez-Lostao, Maitane Ocáriz, José Ramón Paño, Elisa Quílez, Ariel Ramírez, Irene Torres-Ramón, Alfonso Yubero, María Zapata, Rodrigo Lastra
Published 2020-10-01

Activated allogeneic NK cells preferentially kill poor prognosis B-cell chronic lymphocytic leukemia cells

by Diego Sanchez-Martinez, Pilar Lanuza, Natalia Gomez, Aura Muntasell, Elisa Cisneros Leralta, Manuela Moraru, Gemma Azaceta, Alberto Anel, Luis Martínez-Lostao, Martin Villalba, Luis Palomera, Carlos Vilches, Jose A García Marco, Julian Pardo, Julian Pardo
Published 2016-10-01